These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Tislelizumab-Induced Toxic Epidermal Necrolysis-Like Cutaneous Adverse Reaction: Rare Complication of Immune Checkpoint Inhibitor Therapy. Yang X; Xu S Am J Ther; 2024 Jul-Aug 01; 31(4):e470-e474. PubMed ID: 38976533 [No Abstract] [Full Text] [Related]
12. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study. Auquier-Dunant A; Mockenhaupt M; Naldi L; Correia O; Schröder W; Roujeau JC; Arch Dermatol; 2002 Aug; 138(8):1019-24. PubMed ID: 12164739 [TBL] [Abstract][Full Text] [Related]
13. Nivolumab-associated Stevens-Johnson syndrome in a patient with lung cancer. Gracia-Cazaña T; Padgett E; Calderero V; Oncins R Dermatol Online J; 2021 Mar; 27(3):. PubMed ID: 33865285 [TBL] [Abstract][Full Text] [Related]
14. Predicted Value of PD-L1 for Patients With Cervical Cancer Treated With Pembrolizumab. Luo PH; Mo DC; Wang HL; Liang XJ; Huang JF J Clin Oncol; 2024 May; 42(13):1596. PubMed ID: 38452320 [No Abstract] [Full Text] [Related]
16. Pembrolizumab-induced Toxic Epidermal Necrolysis in a Patient with Metastatic Esophageal Adenocarcinoma. Gallo Marin B; Oliva R; Kahn B; Borgovan T; Brooks BE; Massoud CM R I Med J (2013); 2022 Apr; 105(3):34-36. PubMed ID: 35349618 [TBL] [Abstract][Full Text] [Related]
17. Necroptotic and apoptotic cell death in Toxic Epidermal Necrolysis. Stadler PC; Clanner-Engelshofen BM; Helbig D; Satoh T; Reinholz M; French LE J Dermatol Sci; 2021 Nov; 104(2):138-141. PubMed ID: 34656387 [No Abstract] [Full Text] [Related]
18. Hypothalamic expression of PD-L1: does it mediate hypothalamitis? Iervasi E; Strangio A; Saverino D Cell Mol Immunol; 2019 Jun; 16(6):625-626. PubMed ID: 30979971 [No Abstract] [Full Text] [Related]
19. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: An Analysis of Triggers and Implications for Improving Prevention. Miliszewski MA; Kirchhof MG; Sikora S; Papp A; Dutz JP Am J Med; 2016 Nov; 129(11):1221-1225. PubMed ID: 27086495 [TBL] [Abstract][Full Text] [Related]
20. Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors. La Grenade L; Lee L; Weaver J; Bonnel R; Karwoski C; Governale L; Brinker A Drug Saf; 2005; 28(10):917-24. PubMed ID: 16180941 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]